Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective Post-Marketing Surveillance of GOOFICE 5 mg Tablet in Chronic Constipation
jRCT1080223950Completed
- Sponsor
- EA Pharma Co., Ltd.
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of elobixibat in chronic constipation, sponsored by EA Pharma Co., Ltd. Started Jun 2018; status: completed.
02
Drugs
elobixibat
03
Conditions
chronic constipation
Beyond the preview
Go deeper on jRCT1080223950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223950.